Theraclone Sciences Signs its First Major Antibody Deal with Pfizer
By Heather Cartwright
Pharma Deals Review: Vol 2011 Issue 1 (Table of Contents)
Published: 31 Jan-2011
DOI: 10.3833/pdr.v2011.i1.1427 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Pfizer has signed its second antibody discovery deal of January 2011, this time partnering with Seattle-based Theraclone Sciences...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS